Citation Information :
Dubey A, Patel SS, Yadav A. Multifactorial Analysis of Biliary Infection in Patients with Hepato-pancreatico-biliary and Associated Intraabdominal Malignancies Admitted to a Teaching Hospital in Northern India. Euroasian J Hepatogastroenterol 2023; 13 (1):10-17.
Background: Blockage of the biliary tract is commonly caused by malignant tumors leading to deranged liver function, responsible for poor prognosis and a high rate of bacteriobilia leading to mortality.
Material and methods: We collected retrospective data from the hospital information system and laboratory registers in our department from 2021 to 2022 to evaluate biliary infections in patients with hepato-pancreatico-biliary and associated intraabdominal malignancies.
Result: A total of 118 (118/234, 50.43%) patients’ bile samples were estimated in this study. Patients’ average age was 53.02 ± 13.49 years, with more patients below the age of 65 years among those with infected bile samples. Eight patients were infected by 102 pathogenic microorganisms. The most common pathogenic microorganism responsible for biliary infection in patients with abdominal malignancies was Escherichia coli (38/102, 37.25%) followed by Klebsiella pneumoniae (21/102, 20.59%) and Enterococcus spp. (18/102, 17.65%). Underlying comorbidities like diabetes mellitus, hypothyroidism, hypoproteinemia, chronic liver disease, immunosuppression, chronic kidney disease, increased hospital stay, admission to the intensive care unit (ICU), and presence of percutaneous transhepatic biliary drain were statistically significant risk factors for isolation of multidrug-resistant pathogenic bacteria.
Conclusion: Our study guided physicians in identifying the associated demographic characteristics, risk factors, and the spectrum of pathogens responsible for bacteriobilia in abdominal cancer patients along with the antibiotic resistance pattern among these isolates and better selection of antibiotics and antibiotic prophylaxis for patients at risk of developing biliary tract infections with multidrug-resistant pathogens.
Moghimi M, Marashi SA, Salehian MT, et al. Obstructive jaundice in Iran: Factors affecting early outcome. Hepatobiliary Pancreat Dis Int 2008;7(5):515–519. PMID: 18842499.
Riaz A, Pinkard JP, Salem R, et al. Percutaneous management of malignant biliary disease. J Surg Oncol 2019;120(1):45–56. DOI: 10.1002/jso.25471.
GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2018;392(10159):1736–1788. DOI: 10.1016/S0140-6736(18)32203-7.
Abubakar II, Tillmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. The Lancet 2015;385(9963):117–171. DOI: 10.1016/S0140-6736(14)61682-2.
Haag GM, Herrmann T, Jaeger D, et al. Outcomes and risk factors for cancer patients undergoing endoscopic intervention of malignant biliary obstruction. BMC gastroenterology 2015;15(1):1–7. DOI: https://doi.org/10.1186/s12876-015-0399-7.
Gotthardt DN, Weiss KH, Rupp C, et al. Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation. Endoscopy 2013;45(11):890–896. DOI: 10.1055/s-0033-1344713.
Kawecki D, Chmura A, Pacholczyk M, et al. Bacteria isolated from bile samples of liver recipients in the early period after transplantation: Epidemiology and susceptibility of the bacterial strains. Transplant Proc 2007;39(9):2807–2811. DOI: 10.1016/j.transproceed.2007.08. 044.
Bert F, Larroque B, Paugam-Burtz C, et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: An analysis of 259 episodes. Liver Transpl 2010;16(3):393–401. DOI: 10.1002/lt.21991.
Herzog T, Belyaev O, Hessam S, et al. Bacteribilia with resistant microorganisms after preoperative biliary drainage–the influence of bacteria on postoperative outcome. Scand J Gastroenterol 2012;47(7):827–835. DOI: 10.3109/00365521.2012.679684.
Csendes A, Fernandez M, Uribe P. Bacteriology of the gallbladder bile in normal subjects. Am J Surg 1975;129(6):629–631. DOI: 10.1016/0002-9610(75)90334-7.
Kaya M, Beştaş R, Bacalan F, et al. Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients. World J Gastroenterol 2012;18(27): 3585–3589. DOI: 10.3748/wjg.v18.i27.3585.
Negm AA, Schott A, Vonberg RP, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010;72(2): 284–291. DOI: 10.1016/j.gie.2010.02.043.
Zhao J, Wang Q, Zhang J. Changes in microbial profiles and antibiotic resistance patterns in patients with biliary tract infection over a six-year period. Surg Infect (Larchmt) 2019;20(6):480–485. DOI: 10.1089/sur.2019.041.
Yun SP, Seo HI. Clinical aspects of bile culture in patients undergoing laparoscopic cholecystectomy. Medicine (Baltimore) 2018;97(26):e11234. DOI: 10.1097/MD.0000000000011234.
Zhao C, Liu S, Bai X, et al. A retrospective study on bile culture and antibiotic susceptibility patterns of patients with biliary tract infections. Evid Based Complement Alternat Med 2022;2022(Article ID: 9255444):1–11. DOI: 10.1155/2022/9255444.
Kruis T, Güse-Jaschuck S, Siegmund B, et al. Use of microbiological and patient data for choice of empirical antibiotic therapy in acute cholangitis. BMC Gastroenterol 2020;20(1):65. DOI: 10.1186/s12876-020-01201-6.
Reiter FP, Obermeier W, Jung J, et al. Prevalence, resistance rates, and risk factors of pathogens in routine bile cultures obtained during endoscopic retrograde cholangiography. Dig Dis 2021;39(1):42–51. DOI: 10.1159/000509289.
Rupp C, Bode K, Weiss KH, et al. Microbiological assessment of bile and corresponding antibiotic treatment: A strobe-compliant observational study of 1401 endoscopic retrograde cholangiographies. Medicine (Baltimore) 2016;95(10):e2390. DOI: 10.1097/MD. 0000000000002390.
Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: Antimicrobial therapy for acute cholangitis and cholecystitis. Journal of Hepato-Biliary-Pancreatic Sciences 2018;25(1):3–16. DOI: https://doi.org/10.1002/jhbp.518.
Maxwell DW, Jajja MR, Ferez-Pinzon A, et al. Bile cultures are poor predictors of antibiotic resistance in postoperative infections following pancreaticoduodenectomy. HPB (Oxford) 2020;22(7): 969–978. DOI: 10.1016/j.hpb.2019.10.016.
Okamura K, Tanaka K, Miura T, et al. Randomized controlled trial of perioperative antimicrobial therapy based on the results of preoperative bile cultures in patients undergoing biliary reconstruction. J Hepatobiliary Pancreat Sci 2017;24(7):382–393. DOI: 10.1002/jhbp.453.